Viewmind

Innovative development for precision measurement of neurocognitive health.

ViewMind is a digital health company specializing in cutting-edge solutions for accurate assessment of neurocognitive disorders.

 

ViewMind’s technology relies on ocular digital phenotyping to assess the cognitive status of the patient.

Ongoing collaborations

Group 10701
Group 10702
Group 10703
Group 10704
Group 10705
Group 10706
Group 10707
Group 10708

About ViewMind

Based on 20 years of scientific research

ViewMind’s fundamental technology is based on research and development led by Dr. Gerardo Fernandez, ViewMind’s Chief Science Officer and Co-founder. ViewMind developed a technology that phenotypes eye movement responses to visual stimuli and the functioning of specific cognitive domains and related areas of the brain.

 

ViewMind is collaborating with various academic institutions, hospitals, research facilities, key opinion leaders, and pharmaceutical companies to test and iterate on this breakthrough technology.

 

We are interested in additional partnerships for:

 

  • Commercial Phase I, II & III, IV pharmaceutical clinical studies for therapeutics that alter cognitive function.
  • Commercialization partners.
  • New studies with clinical centers, and patient advocacy groups.

Awards and Recognition

ViewMind has been recognized as an innovative healthcare
leader by these organizations:

ViewMind Leadership Team

We are a team of neuroscientists, pharmaceutical executives , serial entrepreneurs, seasoned engineers, and data scientists. 
Read More

  • Executives and founders

  • Board of Directors

  • Scientific Advisory Board 

Mark Edwards
CEO & Founder

Serial entrepreneur, CEO, chairman, founder, board member and builder of market leaders in both private and public companies.
brain health diagnosis

Danilo Verge MD MBA
CMO & COO

A pharmaceutical executive with over 20 years of experience in global medical roles, including Novo Nordisk, AstraZeneca and Zealand Pharma.
brain assessment test

Renata Afonso
President of LATAM Operations and global Chief Marketing Officer.

Over 25 year experience with tier 1 media companies, including 15 years as CEO. Chair person of UNICEF Brazil.

Abhi Vase
Chief Commercial Officer

Healthcare executive with 20 years of experience and multiple startup exits to Medtronic, St. Jude Medical and Abbott in cardiology, metabolic and neurology.

Matias Shulz
CPO

Seasoned entrepreneur, founder and digital health executive.
Daniel D'Agostino MBA

Ariel Arelovich PhD
CTO

Full-stack software development leader and eye-tracking specialist.
brain health diagnosis

Renata Afonso
President of LATAM Operations and global Chief Marketing Officer.

Over 25 year experience with tier 1 media companies, including 15 years as CEO. Chair person of UNICEF Brazil.

Gerardo Fernandez PhD
CSO & Founder

Scientific researcher with 20+ years of experience researching eye movement patterns, neuroscience, and artificial intelligence.
brain assessment

Matt Heller
VP Business Development

Business development executive with a neurology, psychiatry and mental health focus.

Gerardo Fernandez PhD Director

Mark Edwards
Director & Chairman

Serial entrepreneur, CEO, chairman, founder, board member and builder of market leaders in both private and public companies.
Skype_Picture_2023_04_10T05_36_47_453Z-removebg-preview 4

Leesa Soulodre MBA
Observer

Founder and Managing Partner of R3i Ventures, a seed-stage VC Fund based in Luxembourg, Singapore and Silicon Valley.

Screenshot_2023-04-01_at_8.12 6 (1)
Screenshot_2023-04-01_at_8.12 6 (1)

Daniel D'Agostino MBA
Director and Audit Chair

Over 20 years in healthcare as head of investment banking or as a biotechnology CFO.
Daniel D'Agostino MBA

Scarlett Chen
Director

Managing Partner, Verge HealthTech Fund. Previously Managing Director at Prudential Corporation Asia & investment banker at Merrill Lynch & Barclays.
Screenshot_2023-04-01_at_8.12 7

Nicolás Tognalli PhD
Director

Founder and managing partner of CITES, a deeptech early stage VC fund.

Screenshot_2023-04-01_at_8.12 9

Mónica Blatyta
Observer

Managing Partner Solum Capital, an alternative investment venture capital and private equity fund.
Mónica Blatyta Observer

Gerardo Fernandez PhD
Director

Scientific researcher with 20+ years of experience researching eye movement patterns, neuroscience, and artificial intelligence.
brain assessment

Francisco Lopera MD

Professor, Director and founder of the Antioquia Neuroscience Group at the University of Antioquia in Medellín, Colombia. Dr. Lopera is one of the world’s leading specialists on Alzheimer’s & neurodegenerative disorders.

Screenshot_2023-04-01_at_8.12 5
Walter Greenleaf PhD

Walter Greenleaf PhD

Dr. Greenleaf is a Stanford University research neuroscientist and medical product developer and one the world’s leading authorities in the use of virtual reality technology in healthcare.

Screenshot_2023-04-01_at_8.12 4

Danilo Verge MD MBA

A pharmaceutical executive with over 20 years of experience in global medical roles, including Novo Nordisk, AstraZeneca and Zealand Pharma.

Markedwards 1

Juan Granada MD

CEO of the cardiovascular research foundation CRF in New York. Dr. Granada is one of the leading researchers in the translational validation of novel cardiovascular therapies.
Screenshot_2023-04-01_at_8.12 1-2
Screenshot_2023-04-01_at_8.12 6

Mario Parra MD PhD

An award-winning neuroscientist for innovative research in Alzheimer’s biomarkers and a Professor at Strathclyde University.
Screenshot_2023-04-01_at_8.12 6
Mark email read

To be updated on
ViewMind news please
click buttons

To contact ViewMind

    Brain Health for Life
    Easy to perform. Non-invasive.

    Precision Neurology.

    Facebook-f Twitter Instagram

    Company Information

    General Links

    © Copyright Viewmind 2018 – 2023 | All rights reserved

    Brain Health for Life
    Easy to perform. Non-invasive.

    Precision Neurology.

    Youtube Linkedin

    Company Information

    General Links

    Group 1075df9
    © Copyright Viewmind 2018 – 2023 | All rights reserved